Inhibition of cell growth induced by photosensitizer PP(Arg)2-mediated photodynamic therapy in human breast and prostate cell lines. Part I

Photodiagnosis and Photodynamic Therapy

Volumn 8, Issue 1, 2011, Pages 39-48

  Nowak Stepniowska, Agata ^a   Malecki, Maciej ^b   Wiktorska, Katarzyna ^c   Romiszewska, Anna ^a   Padzik Graczyk, Alfreda ^a  

^a MILITARY UNIVERSITY OF TECHNOLOGY   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

Breast cancer cell lines; Cancer growth stimulation; Clonogenic assay; Photodynamic therapy; Prostate cancer cell lines

Indexed keywords

DIARGININE PROTOPORPHYRIN 9; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; UNCLASSIFIED DRUG;

ANDROGEN THERAPY; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL STRAIN LNCAP; CELL STRAIN MCF 7; CLONOGENIC ASSAY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTATE CANCER;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSTATIC NEOPLASMS; PROTOPORPHYRINS;

EID: 79951580625     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2010.09.002     Document Type: Article

References (51)

1. Kessel D. Photodynamic therapy: from beginning. Photodiagn Photodyn Ther 2004, 1:3-7.
2. Schuitmaker J.J., Baas P., van Leengoed H.L.L.M., van der Meulen F.W., Star W.M., van Zandwijk N. Photodynamic therapy: a promising new modality for the treatment of cancer. J Photochem Photobiol B: Biol 1996, 34:3-12.
3. Brown S.B., Brown E.A. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 2004, 5:497-508.
4. Sharman W.M., Allen C.M., van Lier J.E. Photodynamic therapeutics: basic principles and clinical applications. Therapeutic Focus 1999, 11(4):1359-6446.
5. Henderson B.W., Dougherty T.J. How does photodynamic therapy work?. Photochem Photobiol 1992, 1(55):145-157.
6. Kübler A.C. Photodynamic therapy. Med Laser Appl 2005, 20:37-45.
7. Graczyk A. Photodynamic diagnosis and treatment of cancer 1999, Bellona, Warszawa, p. 21-159 (Chapters 1-2, in Polish).
8. Ricchelli F., Gobbo S., Jori G., Moreno G., Vinzens F., Salet C. Photosensitization of mitochondria by liposome-bound porphyrins. Photochem Photobiol 1993, 58(1):53-58.
9. Reddi E., Jori G. Stedy-state and time-resolved spectroscopic studies of photodynamic sensitizers: porphyrins and phthalocyanines. Res Chem Intermed 1988, 10:241-268.
10. Chow Y.F., Dolphin D., Paine J.P., McGarvey D., Pottier R., Truscott T.G. The excited states of covalently linked dimeric porphyrins. I: the excited singlet states. J Photochem Photobiol B 1988, 2(2):253-263.
11. Ricchelli F. Photopysical properties of porphyrins in biological membranes. J Photochem Photobiol B 1995, 29:109-118.
12. Sternberg E.D., Dolphin D. Porphyrin-based photosensitizers for use in photodynamic therapy. Tetrahedron 1998, 54:4151-4202.
13. Ye S., Czuba M., Romiszewska A., Karolczak J., Graczyk A. Investigation of photo-physical properties of selected diaminoacid protoporphyrin derivatives PP(AA)Arg2, I determination of quantum yield of fluorescenc. Opt Appl 2003, 2-3(XXXIII0):489-503.
14. Stief T. The physiology and pharmacology of singlet oxygen. Med Hypotheses 2003, 60(4):567-572.
15. Oleinick N.L., Evans H.E. The photobiology of photodynamic therapy: cellular targets and mechanisms. Rad Res 1998, 150(Suppl.):146-156.
16. Castano A.P., Demidova T.N., Hamblin M.R. Mechanisms in photodynamic therapy: part three-photodensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiagn Photodyn Ther 2005, 2:91-106.
17. Castano A.P., Demidova T.N., Hamblin M.R. Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death. Photodiagn Photodyn Ther 2005, 2:1-23.
18. Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumors. J Photochem Photobiol B: Biol 1997, 39:1-18.
19. Plaetzer K., Kiesslich T., Verwanger T., Krammer B. The modes of cell death induced by PDT: an overview. Med Laser Appl 2003, 18:7-19.
20. Oleinick N.L., Morris R., Belichenko I. The role of apoptosis in response to photodynamic therapy: what, where, why how. Photochem Photobiol Sci 2002, 1:1-21.
21. Buytaert E., Dewaele M., Agostinis P. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta 2007, 1776:86-107.
22. van Duijnhoven F.H., Aalbers R.I.J.M., Rovers J.P., Terpstra O.T., Kuppen P. The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology 2003, 207:105-113.
23. Nowis D., Stokłosa T., Legat M., Issat T., Jakóbisiak M., Gołaogonekb J. The influence of photodynamic therapy on the immune response. Photodiagn Photodyn Ther 2005, 2:283-298.
24. Cecic I., Parkins S., Korbelik M. Induction of systemic neutrphill response in mice by photodynamic therapy of solid tumors. Photochem Photobiol 2001, 74(5):712-720.
25. Cecic I., Sun J., Korbelik M. Role of complement anaphylatoxin C3a in photodynamic therapy-elicited engagement of host neutrophils and other immune cells. Photochem Photobiol 2006, 82:558-562.
26. de Vree W.J.A., Essers M.C., Koster J.F., Sluiter W. Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. Cancer Res 1997, 57:2555-2558.
27. Ceci I., Stott B., Korbelik M. Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy. Int Immunopharmacol 2006, 6:1259-1266.
28. Gollnick S.O., Evans S.S., Baumann H., et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer 2003, 88:1772-1779.
29. Cecic I., Korbelik M. Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett 2002, 183:43-51.
30. Suresh S. Biomechanics and biophysics of cancer cells. Acta Biomater 2007, 3:413-438.
31. Synder F., Wood R. Alkyl alk-1-enyl-ethers of glycerol in lipids from normal and neoplastic tissue. Cancer Res 1969, 29:251-257.
32. Howard B.V., Morris H.P., Bailey J.M. Ether-lipids, glycerol phosphate dehydrogenase and growth rate in yumors and cultured cells. Cancer Res 1972, 32:1533-1538.
33. Palmero E.I., Ashton-Prolla P., da Rocha J.C., et al. Clinical characterization and risk profile of individuals seeking genetic counseling for hereditary breast cancer in Brazil. J Gen Couns 2007, 16(3):363-371.
34. Bartsch H., Dally H., Popanda O., Risch A., Schmezer P. Genetic risk profiles for cancer susceptibility and therapy response, recent results. Cancer Res 2007, 174:19-36.
35. van der Rhee H.J., de Vries E., Coebergh J.W. Favourable and unfavourable effects of exposure to sunlight. Neder Tijdschrift voor Geneeskunde 2007, 151(2):118-122.
36. Broeks A., Braaf L.M., Huseinovic A., Nooijen A., Urbanus J., Hogervorst B.F. Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study. Breast Cancer Res 2007, 9(2):R26.
37. Loizidou M., Marcou Y., Anastasiadou V., Newbold R., Hadjusavvas A., Kyriacou K. Contribution of BRCA1 and BRCA2 gerline mutations to the incidence of early-onset breast cancer in Cyprus. Clin Gen 2007, 71(2):165-170.
38. Colasanti A., Kisslinger A., Liuzzi R., et al. Hypericin photosensitization of tumor and metastatic cell lines of human prostate. J Photochem Photobiol B: Biol 2000, 54:103-107.
39. Bissonauth V., Shatenstein B., Ghadirian P. Nutrition and breast cancer among sporadic cases and gene mutation carriers: an overview. Cancer Detect Prev 2008, 32:52-64.
40. Allison R.R., Sibata C., Downie G.H., Cuenca R.E. Photodynamic therapy of the intact breast. Photodiagn Photodyn Ther 2006, 4:139-146.
41. Ronald B., Xiao Z., Tulip J., Moore H.D. A comparison of susceptibility to photodynamic treatment between endothelial and tumor cells in vitro and in vivo. Photodiagn Photodyn Ther 2007, 4:160-169.
42. Burch S., Bisland S.K., Bogaards A., et al. Photodynamic therapy for the treatment of vertebral metastases in a rat model of human breast carcinoma. J Orthop Res 2005, 23:995-1003.
43. Graczyk A. Photodynamic diagnosis and treatment of cancer 1999, Bellona, Warszawa, p. 117-8 (Chapter 2, in Polish).
44. Misiewicz-Krzemińska I., Skupińska K., Graczyk A., Kasprzycka-Guttman Influence of protoporphyrin IX amino acid substituents on affinity to human breast adenocarcinoma MCF-7 cells. Biotech Histochem 2009, 84(1):1-7.
45. Kowalska A., Graczyk A., Kwaśny M., Ye Sue, Miłosz E., Podhajska A. Diaminoacid derivatives of protoporphyrine used as photosensitizers in photodynamic method of tumor diagnosis and treatment. SPIE 2003, 5229:91-96.
46. Żołaogonekdek T., Bich Nhi N., Jagiełło I., Graczyk A., Rytka R. Diamino acid derivatives of porphyrins penetrate into yeast cells, induce photodamage, but have no mutagenic effect. Photochem Photobiol 1997, 66(2):253-259.
47. Molyneux P. The use of stable free radical diphenylpicrylhydrazyl (DPPH) for estimating antioxidant activity. Songklananakrin J Sci Technol 2004, 26(2):211-219.
48. Arnao M.B. Some metodological problems in the detremination of antioxidant activity using chromogen radicals: a practical case. Trends Food Sci Tech 2000, 11:419-421.
49. Kwitniewski M., Juzeniene A., Ma L., Glosnicka R., Graczyk A., Moan J. Diamino acid derivatives of PPIX as potential photodensitizers for photodynamic therapy of squamous cell carcinoma and prostate cancer: in vitro studies. J Photochem Photobiol B: Biol 2009, 94:214-222.
50. Kwitniewski M., Kunikowska D., Dera-Tomaszewska B., et al. Influence of diamino acid derivatives of protporphyrin IX on mouse immnunological system: preliminary results. J Photochem Photobiol B: Biol 2005, 81:129-135.
51. You Y., Gibson S.L., Detty M.R. Phototoxicity of core-modified porphyrin and induction of apoptosis. J Photochem Photobiol B: Biol 2006, 85:155-162.